Coronavirus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10130701
APP PUB NO 20170216427A1
SERIAL NO

15328179

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE PIRBRIGHT INSTITUTEPIRBRIGHT WOKING SURREY GU24 0NF

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bickerton, Erica Woking, GB 4 21
Britton, Paul Woking, GB 6 25
Keep, Sarah Woking, GB 2 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 20, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 20, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00